Concepedia

Author

Yuki Tomizawa

PTC Therapeutics (United States)

Also Known As

Y. Tomizawa, Yuki Tomizawa

7

Publications

1.4K

Citations

5

H-Index

9

Concepts

All Affiliations

PTC Therapeutics (United States)University of Massachusetts Chan Medical School
YT

About

Yuki Tomizawa is an author at PTC Therapeutics (United States) specializing in genetics, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

1.2K

2

Cell Biology

1

1

47

3

Molecular Genetics

1

1

1.1K

4

Obstetrics

1

1

47

5

Pharmacology

1

1

47

Yuki Tomizawa

×

4

Publications

1.4K

Citations

4

H-Index

YearCitations

PTC124 targets genetic disorders caused by nonsense mutations

Ellen Welch, Elisabeth R. Barton, Jin Zhuo,

Nature

2007

1.1K

Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression

Bijoyita Roy, Westley J. Friesen, Yuki Tomizawa,

Proceedings of the National Academy of Sciences

2016

221

The nucleoside analog clitocine is a potent and efficacious readthrough agent

Westley J. Friesen, Christopher R. Trotta, Yuki Tomizawa,

RNA

2017

47

The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential

Westley J. Friesen, Briana Johnson, Jairo Sierra,

PLoS ONE

2018

38

Page 1